Lochness Medical Supplies
Lochness Medical Supplies is a US distributor of Rapid Response™ point-of-care diagnostics, serving staffing agencies, treatment centers, harm reduction programs, and clinics with drug screening, infectious disease, and harm reduction tests manufactured by BTNX Inc.
- Company typePrivate
- Founded2011
- HeadquartersBuffalo, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Lochness Medical Supplies does
Lochness Medical Supplies Inc. is a privately held US distributor of Rapid Response™ point-of-care diagnostic tests, headquartered in Buffalo, NY and operating under Ontario governing law. Founded in 2011, the company distributes products manufactured by BTNX Inc. across all 50 US states and into Canada, serving staffing agencies, addiction treatment centers, physician offices, diagnostic laboratories, harm reduction organizations, government health authorities, educational institutions, and individual consumers. Its portfolio spans drug screening (multi-drug saliva cups, urine cups with vacuum lids), harm reduction testing (fentanyl, xylazine, medetomidine, benzodiazepine, nitazene strips), spiked-drink detection (GHB cards), infectious disease (COVID-19 antigen tests), urinalysis, fertility testing, cancer screening (Fecal Immunochemical Test), alcohol testing, and medical accessories. Most products are based on rapid lateral flow immunoassay technology with results delivered in 1–10 minutes; the company also offers the RapidReader App for automated result interpretation and the RapidRemote AI-powered virtual proctoring service for remote supervised drug screening. Manufacturing is conducted in ISO 13485:2016 MDSAP and ISO 9001:2008 certified facilities, with regulatory clearances from FDA (EUA), Health Canada, CE Mark, and CLIA Waived status; harm reduction products are independently validated by Johns Hopkins Bloomberg School of Public Health and Ghent University. The revenue model combines unit-based consumables sales with two subscription-style services (RapidRemote and RapidReader App), distributed through an e-commerce storefront, B2B/enterprise sales with account management, and the broader BTNX distribution network. The company employs 11–50 people, has raised no disclosed outside funding, and reports no publicly available revenue figures.
Lochness Medical Supplies firmographics
Firmographics- Name
- Lochness Medical Supplies
- Legal name
- Lochness Medical Supplies Inc.
- Website
- https://lochnessmedical.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Lochness Medical Supplies is a US distributor of Rapid Response™ point-of-care diagnostics, serving staffing agencies, treatment centers, harm reduction programs, and clinics with drug screening, infectious disease, and harm reduction tests manufactured by BTNX Inc.
- Ownership category
- akta.pro rank
Lochness Medical Supplies industry classification
Industry- Product category
- Point-of-Care Diagnostics Distribution
- NAICS
- Medical and Diagnostic Laboratories (62151), Testing Laboratories and Services (541380), Other Scientific and Technical Consulting Services (541690)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)
- akta.pro secondary industries
- Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
Keywords
Where Lochness Medical Supplies is headquartered
LocationHeadquarters
- HQ city
- Buffalo
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Lochness Medical Supplies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure
Revenue model
- Diagnostic Test Products Sales: Revenue generated from sale of Rapid Response™ point-of-care diagnostic tests including drug screening, infectious diseases, women's health, urinalysis, and cancer screening products. Products sold in various kit sizes and configurations with per-unit pricing.
- Medical Accessories Sales: Sale of consumables and accessories required for rapid testing including urine specimen cups, gloves, lancets, nasal aspirate specimen traps, vacuum transfer tubes, and masks.
- RapidRemote Proctoring Service: Virtual proctoring service subscription enabling remote drug screening with AI-powered monitoring and documentation. Integrates with customer ATS/EMR/EHR systems.
- RapidReader App Software: Software service for automated test result interpretation and database upload. Streamlines workflow for organizations performing drug screening.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | COVID-19 Antigen Test OTC |
| Unit Pricing | Pay-as-you-go | COVID-19 Antigen Test POC |
| Unit Pricing | Pay-as-you-go | Benzodiazepine Test Strips |
| Unit Pricing | Pay-as-you-go | Nitazene Test Strips |
| Unit Pricing | Pay-as-you-go | Spiked Drink Test GHB |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Lochness Medical Supplies product offering
Product offeringCore offering
Lochness Medical Supplies Inc. is a premier US distribution company for the Rapid Response™ brand of point-of-care diagnostic tests, including drug screening (urine and saliva), harm reduction strips (fentanyl, xylazine, medetomidine, benzodiazepine, nitazene), infectious disease tests (COVID-19, Strep A, RSV, H. pylori), urinalysis, fertility testing, and colorectal cancer screening (FIT). The company also offers clinical, procedural, and financial consulting services to healthcare providers and runs the AI-powered RapidRemote virtual proctoring service and the RapidReader App for automated workflow.
Product overview
Lochness Medical Supplies Inc. is a premier distribution company carrying Rapid Response™ point of care diagnostics in the United States. Their product portfolio encompasses harm reduction testing (Fentanyl, Xylazine, Medetomidine, Benzodiazepine, and Nitazene test strips), drug screening solutions (multi-drug saliva test cups, urine cups with vacuum lids, ESA tests), alcohol testing (saliva and urine), spiked drink detection (GHB detection cards), infectious disease testing (COVID-19 antigen tests), urinalysis products, fertility testing, cancer screening (Fecal Immunochemical Test/FIT kits), and medical accessories (specimen cups, gloves, lancets, transfer tubes). The company offers the RapidRemote virtual proctoring service for remote drug screening and the RapidReader App for automated result capture. Products are manufactured by BTNX Inc. and distributed under the Rapid Response™ brand with ISO certifications and regulatory approvals from FDA, Health Canada, and CE marking.
Differentiator
Problem solved
Functional benefit
Brands
- Rapid Response: The Rapid Response brand guarantees quality and value for the medical device market. Products are CE Marked and approved under FDA, Health Canada, and other regulatory bodies around the world.
Products and services
- Rapid Response™ Fentanyl Test Strip
Quantifiable outcome
- 98.0% accuracy for Fecal Immunochemical Test (FIT) in detecting colorectal cancer indicators
- +3 more outcomes
Companies that use Lochness Medical Supplies
Customer profileNamed customers6 records
Segments7 records
Lochness Medical Supplies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature5 records
Lochness Medical Supplies partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- BTNX Inc.coreBTNX Inc. is the manufacturer of Rapid Response™ brand products. Lochness Medical serves as the US distribution partner for BTNX products. BTNX holds ISO 13485:2016 MDSAP certification for manufacturing and develops products including drug screening tests, infectious disease tests, and diagnostic devices. Products are distributed globally to thousands of customers.
- Vancouver Coastal Health AuthorityminorVancouver Coastal Health Authority distributes Rapid Response™ Fentanyl Test Strips at overdose prevention sites, supervised consumption sites, and in take-home drug testing kits in British Columbia, Canada. Represents adoption of products for harm reduction public health initiatives.
- Johns Hopkins Bloomberg School of Public HealthcoreJohns Hopkins Bloomberg School of Public Health conducted independent evaluation of BTNX Rapid Response Fentanyl Test Strips. Study found BTNX strips showed lowest detection limit and highest accuracy among fentanyl detection methods tested. Validated product for harm reduction drug checking purposes.
- Ghent University Laboratory of ToxicologycoreGhent University conducted research validating BTNX Rapid Response Nitazene Test Strips. Study confirmed strips are capable of detecting wide range of nitazene analogues in authentic street drug samples, supporting harm reduction applications.
- IntertekminorThird-party quality assurance and testing certification organization. Products manufactured in facilities certified by Intertek as conforming to ISO quality management standards.
- California Postsecondary InstitutionsminorCalifornia legislation (AB-1524) requires state universities and community colleges to stock drug testing devices including fentanyl test strips. Products distributed to campus health centers for harm reduction purposes.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Lochness Medical Supplies competitors and assessment
Company assessmentDirect peers
- OraSure Technologies: Specialty diagnostics company offering rapid point-of-care tests including oral fluid drug screening (Intercept) and infectious disease testing - directly competes in Lochness's saliva-based drug screening and POC infectious disease categories.
- BTNX Inc. Manufacturer of the Rapid Response brand products that Lochness distributes in the US. Also serves as a direct distributor in the Canadian market, operating the same product portfolio under identical regulatory certifications.
- Premier Biotech: US-based distributor and manufacturer of rapid drug screening tests and point-of-care diagnostics serving workplace, clinical, and treatment center markets - directly comparable product portfolio and customer segments.
- CLIAwaived Inc. US-based distributor specializing in CLIA-waived point-of-care diagnostic tests to physician offices, occupational health, and workplace drug screening markets - directly comparable distribution model and customer base.
- QuidelOrtho: Major rapid diagnostics manufacturer and distributor offering Sofia-platform rapid antigen tests for infectious diseases (COVID, Strep, RSV) and other POC diagnostics that compete directly with Rapid Response products.
- Drug Testing Solutions: Smaller specialty distributor of rapid drug screening products and harm reduction test strips, often serving treatment centers and staffing agencies - directly comparable niche distribution model.
Broad incumbents
- Henry Schein Medical: Major medical supply distributor serving physician offices, occupational health, and clinical laboratories with POC diagnostics and drug testing products as part of a broader medical supply catalog.
- McKesson Medical-Surgical: Largest US medical-surgical distributor with a broad portfolio that includes POC diagnostic tests, drug screening supplies, and harm reduction products - competes for the same physician office and clinical customer accounts with greater scale.
- Cardinal Health Medical Products: Large medical products distributor offering laboratory and POC diagnostic supplies to healthcare providers and laboratories, competing for institutional customers in the same drug screening and clinical diagnostics verticals.
- Abbott Point of Care: Global diagnostics leader manufacturing and distributing the Binax rapid test platform and other POC products that compete with Rapid Response infectious disease tests while offering broader institutional support.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Lochness Medical Supplies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lochness Medical Supplies leadership team
Management profileNumber of profiles
Profiles1 record
Lochness Medical Supplies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lochness Medical Supplies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lochness Medical Supplies
What does Lochness Medical Supplies do?
Lochness Medical Supplies Inc. is a premier US distribution company for the Rapid Response™ brand of point-of-care diagnostic tests, including drug screening (urine and saliva), harm reduction strips (fentanyl, xylazine, medetomidine, benzodiazepine, nitazene), infectious disease tests (COVID-19, Strep A, RSV, H. pylori), urinalysis, fertility testing, and colorectal cancer screening (FIT). The company also offers clinical, procedural, and financial consulting services to healthcare providers and runs the AI-powered RapidRemote virtual proctoring service and the RapidReader App for automated workflow.
Is Lochness Medical Supplies a public or private company?
Lochness Medical Supplies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Lochness Medical Supplies founded?
Lochness Medical Supplies was founded in 2011. It employs 11 to 50 people.
Where is Lochness Medical Supplies based?
Lochness Medical Supplies is headquartered in Buffalo, United States, in the North America region.
How does Lochness Medical Supplies make money?
Four revenue lines are on record. Diagnostic Test Products Sales are the primary driver. The others are medical Accessories Sales, rapidRemote Proctoring Service and rapidReader App Software.
Who are Lochness Medical Supplies's main competitors?
Direct peers on record are OraSure Technologies, BTNX Inc., Premier Biotech, CLIAwaived Inc., QuidelOrtho and Drug Testing Solutions. Broad incumbents are Henry Schein Medical, McKesson Medical-Surgical, Cardinal Health Medical Products and Abbott Point of Care.
Does Lochness Medical Supplies have an API?
No public API is recorded for Lochness Medical Supplies.
What industry is Lochness Medical Supplies in?
Lochness Medical Supplies's product category is Point-of-Care Diagnostics Distribution. Its primary akta.pro industry code is HLAGAEAF, Microbiology & Infectious Disease Testing (Trial Support), with a secondary code of HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its NAICS code is 62151 and its SIC code is 5122.